Specialites

Alzheimer's Disease

Until recently, there has been no amyloid-targeting treatment available for Alzheimer's disease. We imagine a future where providers have the tools needed to identify, diagnose, select the right treatment, and monitor and visualize treatment response. A future where a strong provider network collaborates with patients and their families to identify signs of Alzheimer’s – even before symptoms begin.

We are here to instill hope in the face of Alzheimer's disease and to make this vision a reality.

Facts and Figures¹

6.7M

Estimated number of Americans are living with Alzheimer’s Disease, which will likely grow to 12.7 M by 2050

7th

leading cause of death in the United States

18B

estimated hours of unpaid care provided by caregivers of people with Alzheimer’s Disease or other dementias

$345B

Projected in annual cost in the US driven by incurable, yet long-care timeline

Discovery

Researchers continue to study how Alzheimer’s Disease changes the brain in the hope of identifying new treatments.

Tracer production

Tracer production is critical in PET imaging, with each tracer produced offering a potential step towards treatment.

Isotope (¹⁸F) tracer production providing a large supply or consistent, reliable, and cost-effective tracers.

Learn more

With a unique, integrated cassette-based design and GMP-quality components, FASTlab 2 New Edition enables regulatory reliability & compliance in small-scale tracer production.

Learn more

Isotope (¹⁸F) tracer production providing a large supply or consistent, reliable, and cost-effective tracers.

Learn more

Diagnosis

Brain imaging (MRI, PET/MR, PET/CT) is a critical component of a confident Alzheimer’s diagnosis.

Brain imaging

Visualization of brain amyloid

Structural imaging by MR is primarily used to rule out other causes of Alzheimer’s symptoms

Offering efficient workflow and productivity solutions for routine scanning, our MRI scanners bring innovation for advanced clinical procedures to deliver patient satisfaction

Learn more

The industry’s most sensitive Time-of-Flight (ToF) PET detector and our most capable MR scanner deliver clarity and patient comfort with every scan

Learn more

Offering efficient workflow and productivity solutions for routine scanning, our MRI scanners bring innovation for advanced clinical procedures to deliver patient satisfaction

Learn more

Treatment

Monitoring amyloid-related imaging abnormality (ARIA) with MR and PET/MR is critical in the course of anti-amyloid AD therapy.

Improved quality and shorter acquisition time

Scan reproducibility

Reducing scan time without impacting image quality can help your practice keep pace with a growing AD population

A deep-learning based reconstruction for improving SNR and image sharpness, while enabling shorter scan times

Learn more

Delivers a compressed-sensing boost to image acceleration for faster and higher-resolution acquisitions.

A deep-learning based reconstruction for improving SNR and image sharpness, while enabling shorter scan times

Learn more

Real-time applications provide motion-correction and distortion artifact reduction during the scan

Reducing unwanted distortion artifacts in diffusion-weighted and diffusion-tensor imaging in challenging anatomical regions

Real-time prospective motion correction technique with minimal scan time penalty and without the need for external cameras or fiducial markers

Reducing unwanted distortion artifacts in diffusion-weighted and diffusion-tensor imaging in challenging anatomical regions

The industry’s most sensitive Time-of-Flight (ToF) PET detector and our most capable MR scanner offer clarity and patient comfort with every scan

Data-driven, retrospective motion correction technology requiring no external hardware and having no impact on the clinical routine

Learn more

Data-driven, retrospective motion correction technology requiring no external hardware and having no impact on the clinical routine

Learn more

Disclaimers

SIGNA PET/MR AIR is a premium configuration of SIGNA PET/MR. Not CE marked. Not available in all regions.
Not CE marked. Not available in all regions.

References

Alzheimer’s Association. (2023). 2023 Alzheimer’s Disease Facts and Figures

Specialites

Alzheimer's Disease

Facts and Figures¹